Entry stagen/a
Check sizen/a
Leads roundsn/a
FocusLife sciences, Food and ag, Climate
Latest fundn/a
Investing team2 peopleNo activity since Sep
Who you would pitch at Checkmate Capital
2 people on the investing team, 2 of them partners who can make the call. Partners are listed first.
Jamie EvansManaging DirectorHe has experience in banking, finance, and capital markets.
Tom PaschallCEO & Co-FounderHe previously worked as an attorney and co-founded Coronal Energy.
Work here and something is wrong? Ask for a correction.
Check size not reported yet.
Bars: how many firms in the atlas report each band. Highlighted: this firm.No recent activity since September 2026. Quiet does not mean closed.
Weekly count of activity updates. Activity is not a confirmed deal.Notable investments
Coya TherapeuticsTela BioNeuroSigmaElucidTriumviraAltis BiosystemsSoteriaCropXLynx BioMonarch Bio
In their words
Checkmate Capital | Investments | Advisory | LicensingCheckmate Capital combines the ownership of cash flow generating assets, commercial, management and transaction advisory services and facilitation of international licenswww.checkmatecapital.net
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckAlert me when Checkmate Capital is active
One email when this firm shows new activity. Nothing else.
Questions
What stage does Checkmate Capital invest in?
Checkmate Capital has not reported an entry stage.
How much does Checkmate Capital invest?
Checkmate Capital has not reported a check size.
Does Checkmate Capital lead rounds?
Checkmate Capital has not reported a lead preference.
Who are the partners at Checkmate Capital?
Jamie Evans (Managing Director), Tom Paschall (CEO & Co-Founder).
Is Checkmate Capital active right now?
No recent activity since September 2026.
Work at Checkmate Capital? Claim or correct this profile.